Charles Schwab Investment Management Inc 10x Genomics, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 651,582 shares of TXG stock, worth $10.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

651,582

Previous 964,682 32.46%

Holding current value

$10.4 Million

Previous $18.8 Million 21.59%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$15.71 - $23.49 $4.92 Million - $7.35 Million	-313,100 Reduced 32.46%	651,582 $14.7 Million
Q2 2024 Aug 12, 2024	BUY	$19.45 - $37.37 $395,321 - $759,545	20,325 Added 2.15%	964,682 $18.8 Million
Q1 2024 May 08, 2024	BUY	$36.08 - $54.3 $704,462 - $1.06 Million	19,525 Added 2.11%	944,357 $35.4 Million
Q4 2023 Feb 06, 2024	BUY	$34.32 - $57.55 $1.12 Million - $1.88 Million	32,709 Added 3.67%	924,832 $51.8 Million
Q3 2023 Nov 08, 2023	BUY	$40.86 - $62.98 $4.64 Million - $7.16 Million	113,651 Added 14.6%	892,123 $36.8 Million
Q2 2023 Aug 09, 2023	BUY	$50.96 - $58.72 $989,898 - $1.14 Million	19,425 Added 2.56%	778,472 $43.5 Million
Q1 2023 May 11, 2023	SELL	$35.33 - $55.79 $91,469 - $144,440	-2,589 Reduced 0.34%	759,047 $42.3 Million
Q4 2022 Feb 13, 2023	BUY	$24.4 - $41.3 $732,048 - $1.24 Million	30,002 Added 4.1%	761,636 $27.8 Million
Q3 2022 Nov 14, 2022	BUY	$28.48 - $52.59 $5.86 Million - $10.8 Million	205,870 Added 39.16%	731,634 $20.8 Million
Q2 2022 Aug 15, 2022	BUY	$36.95 - $82.41 $868,103 - $1.94 Million	23,494 Added 4.68%	525,764 $23.8 Million
Q1 2022 May 13, 2022	BUY	$55.7 - $145.79 $557,779 - $1.46 Million	10,014 Added 2.03%	502,270 $38.2 Million
Q4 2021 Feb 11, 2022	BUY	$135.05 - $182.59 $2.31 Million - $3.12 Million	17,092 Added 3.6%	492,256 $73.3 Million
Q3 2021 Nov 16, 2021	SELL	$145.58 - $192.14 $11.1 Million - $14.6 Million	-75,925 Reduced 13.78%	475,164 $69.2 Million
Q2 2021 Aug 16, 2021	BUY	$134.22 - $202.37 $3.02 Million - $4.56 Million	22,515 Added 4.26%	551,089 $108 Million
Q1 2021 May 17, 2021	BUY	$140.25 - $196.86 $9.94 Million - $14 Million	70,889 Added 15.49%	528,574 $95.7 Million
Q4 2020 Feb 16, 2021	BUY	$126.47 - $163.7 $3.66 Million - $4.73 Million	28,922 Added 6.75%	457,685 $64.8 Million
Q3 2020 Nov 13, 2020	BUY	$87.44 - $125.0 $32.5 Million - $46.4 Million	371,470 Added 648.37%	428,763 $53.5 Million
Q2 2020 Aug 14, 2020	BUY	$58.39 - $89.31 $583,432 - $892,385	9,992 Added 21.12%	57,293 $5.12 Million
Q1 2020 May 15, 2020	BUY	$51.57 - $106.62 $54,148 - $111,951	1,050 Added 2.27%	47,301 $2.95 Million
Q4 2019 Feb 07, 2020	BUY	$46.07 - $79.54 $2.13 Million - $3.68 Million	46,251 New	46,251 $3.53 Million

Others Institutions Holding TXG

# of Institutions

291

Shares Held

94.7M

Call Options Held

263K

Put Options Held

85.1K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.51B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc 10x Genomics, Inc. Transaction History